guggul

Condiciones de salud que guggul puede ayudar a apoyar.

• AbscesosCientífico

  Guggul (as gugulipid) has been tested in small clinical trials for acne. A 1994 trial compared oral gugulipid to tetracycline in nodulocystic acne and found comparable outcomes. A more recent double-blind placebo-controlled study of 30 subjects taking 500 mg twice daily for 90 days showed significant reductions in both inflammatory and non-inflammatory lesion counts versus placebo.

• HipocondríaCientífico

  Guggulsterones prevent oxidation of LDL cholesterol and reduce oxidative stress biomarkers in human subjects. Studies show reductions in malondialdehyde (MDA) and enhanced activity of antioxidant enzymes including superoxide dismutase (SOD) and catalase. These antioxidant properties contribute to guggul's cardioprotective and anti-inflammatory effects.

• Síndrome de Inmunodeficiencia AdquiridaCientífico

  Guggul (Commiphora mukul) resin and its active guggulsterones inhibit farnesoid X receptor (FXR), increasing hepatic LDL receptor expression and reducing LDL-C. Multiple RCTs confirm lipid-lowering effects relevant to arterial plaque reduction. Guggul has been used in Ayurveda for cardiovascular and lipid conditions for millennia.

• EccemaCientífico

  Guggul and its formulations have been studied in both osteoarthritis and rheumatoid arthritis. Small clinical case studies and early trials suggest reductions in pain, stiffness, and swelling. In vitro and in vivo models confirm inhibition of inflammatory mediators relevant to joint destruction.

• HipoglucemiaCientífico

  Guggul has demonstrated anti-platelet and pro-fibrinolytic activities in human clinical studies. A study in coronary artery disease patients found significant reductions in platelet adhesive index and increases in fibrinolytic activity after 30 days. Guggulsterones have also been shown to inhibit platelet aggregation in laboratory studies.

• ApendicitisCientífico

  Guggulsterones suppress NF-κB, a master regulator of inflammatory gene expression, and inhibit COX-2. Human studies have shown reductions in C-reactive protein (CRP) and oxidative stress biomarkers following guggulipid supplementation. This anti-inflammatory action underpins many of guggul's proposed therapeutic applications.

• AmpollasCientífico

  Guggul (Commiphora mukul) is an Ayurvedic resinous gum whose active guggulsterones exert anti-inflammatory effects via inhibition of NF-κB and reduction of inflammatory cytokines. Clinical studies in osteoarthritis have shown improvements in joint pain and function. Guggul has been used in Ayurvedic medicine for thousands of years for joint disorders ('Amavata').

• JuanetesCientífico

  Guggulipid has been studied in multiple clinical trials for its lipid-lowering and cardioprotective effects. Earlier Indian trials (1970s–1990s) found significant reductions in total cholesterol, LDL, and triglycerides with elevations in HDL. A 2003 JAMA randomized controlled trial in U.S. patients with hypercholesterolemia failed to replicate these benefits and found LDL actually increased in some subjects. Evidence is thus mixed.

• Trastorno Pulmonar Obstructivo CrónicoCientífico

  Guggul (Commiphora wightii/mukul) contains active steroidal ketones called guggulsterones (E- and Z-isomers) that influence lipid and energy metabolism through multiple mechanisms, including antagonism of the farnesoid X receptor (FXR) and stimulation of thyroid function. Clinical evidence for lipid-lowering effects is mixed: older Indian trials suggested benefit, while a 2003 randomized controlled trial published in JAMA found no improvement in LDL and a potential LDL increase in some participants. Animal and in vitro evidence for thyroid-mediated metabolic stimulation exists, but robust human trials in this area are lacking.

• Dolor de cabeza (tensión)Científico

  Guggulipid targets multiple molecular pathways central to rheumatoid arthritis pathophysiology, including COX-2, NF-κB, and JAK/STAT. Early clinical research suggests 3,000 mg/day for 4 months may improve RA symptoms. Ayurvedic formulations such as Vatari Guggulu have been evaluated in small controlled trials with reported benefits in joint swelling and pain.

• CitomegalovirusCientífico

  Guggul (Commiphora mukul) resin contains Z-guggulsterone, a ketosteroid that has shown thyroid-stimulatory activity in animal studies, increasing thyroid iodine uptake, thyroid peroxidase activity, and T4-to-T3 conversion. It is used in Ayurvedic medicine as a thyroid stimulant. Robust human clinical trials for thyroid endpoints are lacking.

• Dolor AbdominalTradicional

  Guggul is used in Ayurvedic medicine for internal and external abscesses, attributed to its antimicrobial, anti-inflammatory, and tissue-cleansing properties. Formulations such as Triphala Guggulu are classically indicated for liver abscess and soft-tissue abscesses. No clinical trials are available.

• DisenteríaTradicional

  Guggul (Commiphora mukul resin) is a key Ayurvedic ingredient in Triphala Guggulu, the classical preparation for fistula-in-ano (Bhagandara) and anal fissure. It provides anti-inflammatory, analgesic, and wound-healing properties, and supports bowel regularity. An open-label RCT (PMC 2022, n=46) evaluated Guggulu-based medicated thread plus oral Triphala Guggulu vs. controls in fistula-in-ano, showing statistically significant improvement in pain, discharge, and swelling.

• DispepsiaTradicional

  Guggul formulations such as Singhnad Guggulu are traditionally indicated for anemia in Ayurvedic practice. Guggul is considered a Raktashodhaka (blood purifier), and Vatari Guggulu has been shown in animal studies to increase hemoglobin and RBC counts in arthritic rats.

• Fatiga SuprarrenalTradicional

  Animal studies suggest guggulsterones exert hypoglycemic and insulin-sensitizing effects. An antidiabetic effect has been noted in high-fat diet-induced diabetic rats. No well-designed human clinical trials for blood sugar management with guggul alone have been published.

• EndometriosisTradicional

  In Ayurveda, guggul is described as aromatic and expectorant, useful for Kapha-type respiratory disorders including bronchitis, cough, and nasal catarrh. Inhalation of guggul fumes is a traditional application for respiratory conditions. No clinical trials exist for this indication.

• Válvula IleocecalTradicional

  Guggul resin is used in Ayurvedic medicine as a traditional lipid-lowering agent classified as medohar (fat-reducing). However, controlled human clinical trials have not confirmed cholesterol lowering; one well-controlled RCT of 103 patients found guggulsterones increased LDL by 4–5% with no benefit on TC, HDL, or TG.

• Ojos Inyectados en SangreTradicional

  Guggul (Commiphora mukul resin) is a classical Ayurvedic medicine used for liver, gallbladder, and lipid metabolism for over 2000 years. Active guggulsterones modulate bile acid metabolism via FXR. Traditional use for gallbladder complaints, biliary stasis, and hepatobiliary conditions is documented in Ayurvedic texts since 600 BC.

• InfecciónTradicional

  Guggul (Commiphora mukul) is used in Ayurvedic medicine for hepatobiliary complaints, with guggulsterones identified as its bioactive constituents. Guggulsterones are known antagonists of the farnesoid X receptor (FXR), a nuclear receptor that plays a central role in bile acid synthesis and secretion regulation. While traditional use for gallbladder support is well-established in Ayurveda, direct clinical evidence for gallstone prevention or treatment in humans is limited.

• Miedo (excesivo)Tradicional

  Ayurvedic texts explicitly reference guggul for Vatarakta (gouty arthritis), and Kaisora Guggulu is a classical formulation specifically indicated for gout and elevated uric acid. No human clinical trials for guggul in gout have been published.

• Moretones (prevención)Tradicional

  Guggul has been used traditionally in Ayurveda for obesity and excess body weight, attributed to its ability to enhance metabolic fire (agni) and reduce Ama. Limited clinical data from small double-blind trials show modest results, and a well-designed pilot trial failed to show significant weight-loss benefit compared to placebo.

• BursitisTradicional

  In Ayurveda, guggul-based formulations — particularly Triphala Guggulu — are among the primary treatments for hemorrhoids (Arsha). The anti-inflammatory, astringent, and venotonic properties of guggul are invoked for this indication. No standalone clinical trials for guggul in hemorrhoids have been published.

• Uñas de los dedos (débiles o quebradizas)Tradicional

  Guggulsterones have demonstrated thyroid-stimulating effects in animal studies, including increased iodine uptake by the thyroid, enhanced thyroid peroxidase activity, and increased T3 production. No well-designed human RCTs specifically for hypothyroidism have been published. Traditional Ayurvedic formulations such as Kanchanar Guggulu are prescribed for thyroid disorders.

• FlotadoresTradicional

  Guggulsterone inhibits NF-κB, a central signaling pathway in IBD pathogenesis, in preclinical models. Animal experiments with Z-guggulsterone in colitis models show reduced clinical symptoms and mucosal inflammation. No human clinical trials for IBD with guggul have been published.

• Envenenamiento QuímicoTradicional

  Guggul is described in Ayurveda as a liver stimulant and is used in formulations for liver conditions including liver abscess and hepatic dysfunction. Preclinical studies suggest guggulipid may have hepatoprotective antioxidant effects, but clinical hepatoprotective trials are absent.

• Colesterol (alto)Tradicional

  Guggul is noted in Ayurvedic and clinical literature as a uterine stimulant that encourages menstrual flow (emmenagogue), and is used in formulations for menstrual disorders including dysmenorrhea. It is contraindicated in pregnancy for the same reason. No clinical trials for dysmenorrhea are available.

• GingivitisTradicional

  Guggul addresses multiple components of metabolic syndrome — dyslipidemia, adiposity, and insulin resistance — through complementary mechanisms. Preclinical studies show guggulsterones inhibit adipocyte differentiation, induce adipocyte apoptosis, and have hypoglycemic effects. Pilot and naturalistic human trials have shown modest lipid and weight effects but lack rigorous controlled data specifically for metabolic syndrome.

• Dolor de cabeza (en racimos)Tradicional

  Guggul formulations, particularly Kaishore Guggulu and Rasnadi Guggulu, are used in Ayurvedic medicine for psoriasis and chronic inflammatory skin conditions. The blood-purifying and anti-inflammatory properties of guggul are invoked. No standalone clinical trials of guggul specifically for psoriasis have been identified.

• Corazón (debilidad)Tradicional

  Guggul has been used in Ayurveda for sciatica (Gridhrasi), a Vata-predominant disorder. Its Vatahara (Vata-pacifying) and anti-inflammatory properties are the basis of this traditional use. No human clinical trials for guggul in sciatica are available.

• DebilidadTradicional

  Guggul (Commiphora mukul resin) has been used in Ayurvedic medicine for centuries to treat medoroga (lipid disorders) and is traditionally prescribed for elevated cholesterol and triglycerides. The active guggulsterones are claimed to modulate thyroid hormone and bile acid receptor activity. Clinical RCT evidence in Western populations is inconsistent.

• DifteriaTradicional

  Guggul is classified in Ayurveda as Vrana-ropaka (wound-healing) and has documented traditional use for infected wounds, ulcers, and sores. Its antimicrobial and anti-inflammatory properties are cited as the basis for this action. Modern studies confirm antimicrobial and antioxidant properties but no human wound-healing trials have been conducted.

Sistemas corporales que guggul puede ayudar a apoyar.

• No hay sistemas corporales disponibles.